Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
Chenlo M, Rodriguez-Gomez IA, Serramito R, Garcia-Rendueles AR, Villar-Taibo R, Fernandez-Rodriguez E, Perez-Romero S, Suarez-Fariña M, Garcia-Allut A, Cabezas-Agricola JM, Rodriguez-Garcia J, Lear PV, Alvarez-San Martin RM, Alvarez-Escola C, Bernabeu I, Alvarez CV. Chenlo M, et al. EBioMedicine. 2019 May;43:537-552. doi: 10.1016/j.ebiom.2019.04.007. Epub 2019 Apr 8. EBioMedicine. 2019. PMID: 30975543 Free PMC article.
Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M, García Sanz I, Mínguez Ojeda C, Hanzu F, Mora M, Vicente A, Blanco Carrera C, de Miguel Novoa P, López García MDC, Lamas C, Manjón-Miguélez L, Del Castillo Tous M, Rodríguez de Vera P, Barahona San Millán R, Recasens M, Tomé Fernández-Ladreda M, Valdés N, Gracia Gimeno P, Robles Lazaro C, Michalopoulou T, Álvarez Escolá C, García Centeno R, Barca-Tierno V, Herrera-Martínez AD, Calatayud M. Araujo-Castro M, et al. Front Endocrinol (Lausanne). 2023 Dec 7;14:1279828. doi: 10.3389/fendo.2023.1279828. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38155946 Free PMC article.
Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up.
Lamas C, Febrero B, Casteràs A, Romero-Lluch A, Recio-Córdova JM, Ros I, Iglesias P, Hanzu FA, Araujo-Castro M, Guerrero-Pérez F, Ares J, Menéndez E, Paja M, Álvarez-Escolá C, Librizzi S, Sánchez-Sobrino P, Andres-Pretel F, Calatayud M. Lamas C, et al. Among authors: alvarez escola c. Otolaryngol Head Neck Surg. 2025 Jan;172(1):176-183. doi: 10.1002/ohn.1012. Epub 2024 Oct 13. Otolaryngol Head Neck Surg. 2025. PMID: 39396153
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.
Monteagudo M, Calsina B, Salazar-Hidalgo ME, Martínez-Montes ÁM, Piñeiro-Yáñez E, Caleiras E, Martín MC, Rodríguez-Perales S, Letón R, Gil E, Buffet A, Burnichon N, Fernández-Sanromán Á, Díaz-Talavera A, Mellid S, Arroba E, Reglero C, Martínez-Puente N, Roncador G, Del Olmo MI, Corrales PJP, Oliveira CL, Álvarez-Escolá C, Gutiérrez MC, López-Fernández A, García NP, Regojo RM, Díaz LR, Laorden NR, Guadarrama OS, Bechmann N, Beuschlein F, Canu L, Eisenhofer G, Fassnacht M, Nölting S, Quinkler M, Rapizzi E, Remde H, Timmers HJ, Favier J, Gimenez-Roqueplo AP, Rodriguez-Antona C, Currás-Freixes M, Al-Shahrour F, Cascón A, Leandro-García LJ, Montero-Conde C, Robledo M. Monteagudo M, et al. Among authors: alvarez escola c. Best Pract Res Clin Endocrinol Metab. 2024 Dec;38(6):101931. doi: 10.1016/j.beem.2024.101931. Epub 2024 Aug 29. Best Pract Res Clin Endocrinol Metab. 2024. PMID: 39218714 Free article.
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy.
Marazuela M, Lucas T, Alvarez-Escolá C, Puig-Domingo M, de la Torre NG, de Miguel-Novoa P, Duran-Hervada A, Manzanares R, Luque-Ramírez M, Halperin I, Casanueva FF, Bernabeu I. Marazuela M, et al. Eur J Endocrinol. 2009 Apr;160(4):535-42. doi: 10.1530/EJE-08-0705. Epub 2009 Jan 15. Eur J Endocrinol. 2009. PMID: 19147599
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study.
Marazuela M, Paniagua AE, Gahete MD, Lucas T, Alvarez-Escolá C, Manzanares R, Cameselle-Teijeiro J, Luque-Ramirez M, Luque RM, Fernandez-Rodriguez E, Castaño JP, Bernabeu I. Marazuela M, et al. J Clin Endocrinol Metab. 2011 Feb;96(2):E251-9. doi: 10.1210/jc.2010-1742. Epub 2010 Nov 10. J Clin Endocrinol Metab. 2011. PMID: 21068147
[The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies].
Luque-Ramírez M, Carreño A, Alvarez Escolá C, del Pozo Picó C, Varela da Costa C, Fajardo Montañana C, Gilabert M, Webb S; Grupo Español del estudio OASIS. Luque-Ramírez M, et al. Endocrinol Nutr. 2011 Nov;58(9):478-86. doi: 10.1016/j.endonu.2011.09.002. Epub 2011 Oct 26. Endocrinol Nutr. 2011. PMID: 22032858 Spanish.
Pegvisomant and cabergoline combination therapy in acromegaly.
Bernabeu I, Alvarez-Escolá C, Paniagua AE, Lucas T, Pavón I, Cabezas-Agrícola JM, Casanueva FF, Marazuela M. Bernabeu I, et al. Pituitary. 2013 Mar;16(1):101-8. doi: 10.1007/s11102-012-0382-z. Pituitary. 2013. PMID: 22396133
128 results